台湾地区医疗保险药品支付价格调整体系研究

发布时间：2018-03-31 06:42

本文选题：台湾地区　切入点：医疗保险　出处：《价格理论与实践》2017年04期

【摘要】：2015年5月,国家发改委等7部委共同发布《关于印发推进药品价格改革意见的通知》,实现"最高零售限价"向"医保支付标准"的转变。但目前对于药品支付标准价格调整研究欠缺。我国台湾地区从1999年开始进行定期的药价调查以及相应的调整工作,形成目前以创新程度为基础药品分类、总额控费与个体调价相结合的定期药品支付价格调整体系,且成效显著。通过分析台湾地区药品支付价格调整体系,为我们构建药品支付标准价格调整体系提供借鉴。
[Abstract]:In May 2015, seven ministries and commissions, including the National Development and Reform Commission, jointly issued a notice on printing and issuing opinions on promoting drug price reform, in order to realize the transformation from "maximum retail price limit" to "medical insurance payment standard".However, there is a lack of research on standard price adjustment of drug payment at present.Since 1999, the Taiwan region of China has been conducting regular drug price surveys and corresponding adjustment work, forming the current regular drug payment price adjustment system, which is based on the degree of innovation and combines total control fees with individual price adjustment.And the effect is remarkable.By analyzing the adjustment system of drug payment price in Taiwan, this paper provides a reference for us to construct the standard price adjustment system for drug payment.
【作者单位】：中国药科大学;
【基金】：2015年度国家社科基金重大项目(第二批)《我国创新药物政策环境研究》(批准号:15ZDB167)支持
【分类号】：R95

【相似文献】